San Mateo, CA, United States of America

Martijn Fenaux

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 156(Granted Patents)


Location History:

  • Blacksburg, VA (US) (2007)
  • Redwood City, CA (US) (2007 - 2015)
  • San Mateo, CA (US) (2017 - 2024)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovations of Martijn Fenaux: A Pioneer in GLP-1R Agonist Research

Introduction

Martijn Fenaux, an innovative inventor based in San Mateo, CA, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 16 patents, he has focused his research on compounds that serve as glucagon-like peptide-1 receptor (GLP-1R) agonists, paving the way for advancements in treatments for various diseases.

Latest Patents

Fenaux’s latest patents involve compounds that may be utilized as GLP-1R agonists or their pharmaceutically acceptable salts. These patents provide not only the essential compounds but also pharmaceutical compositions that integrate these findings. Furthermore, they detail methods for preparing the compounds and compositions, alongside their applications in treating or preventing conditions mediated by GLP-1R. This innovation represents a significant leap in therapeutic strategies for managing diseases associated with this receptor.

Career Highlights

Throughout his career, Fenaux has worked with renown institutions, demonstrating his commitment to research and innovation. Notably, he was affiliated with Virginia Tech Intellectual Properties, Inc. and the Iowa State University Research Foundation, Inc. His expertise in the field has allowed him to navigate complex scientific landscapes, contributing to significant advancements in medical research.

Collaborations

Collaboration has been a cornerstone of Fenaux’s journey. Among his notable collaborators are Xiang-Jin Meng and Patrick G. Halbur. Working alongside esteemed colleagues has enabled him to enhance his research outcomes and expand the impact of his inventions within the scientific community.

Conclusion

Martijn Fenaux stands out as a dedicated inventor whose work on GLP-1R agonists holds promise for future therapeutic solutions. His extensive patent portfolio and collaborations not only highlight his innovative spirit but also his contribution to enhancing healthcare through scientific discovery. As research in this area continues to evolve, Fenaux’s work will undoubtedly play a vital role in shaping future treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…